Founder & Chief Medical Officer play a crucial role in any startup. It takes an extraordinary person to fulfil the Founder & Chief Medical Officer role. We have selected these Founder & Chief Medical Officer’s for this list as they are inspiring for a variety of reasons – whether that’s pushing boundaries, creating groundbreaking products, or doing their bit to save the world.
Our analysts did their best to select be best, and most innovative Founder & Chief Medical Officer’s. The list is in no particular order!
Matthew Goodman
Founder & Chief Medical Officer @ Mapmyhealth
FollowMatthew Goodman on Facebook, Twitter or Linkedin.
Spoiler title
Matthew Goodman Chief Medical Officer Matthew studied medicine in the UK, qualifying as a doctor and becoming a general surgeon before specialising in endocrinology and pharmaceutical medicine. He began his career in industry by joining Sanofi, soon moving to Global positions with Novartis in both Switzerland and the US. In 2009 he returned to the UK to lead the Clinical Research programs of Prosidion, an Oxford-based biotechnology company breaking new ground in the treatment of diabetes and obesity. During his time as a research physician, along with his team, he was credited with the successful development of several cardiovascular and diabetes medicines today being used to successfully treat millions of patients worldwide. In 2012, Matthew founded Mapmyhealth, a company dedicated to the use of innovative technologies in the treatment of long-term conditions, from diabetes to cancer. Mapmyhealth now deliver their digital therapeutics to thousands of patients across the NHS and beyond, helping to advance care, improve disease management, prevent complications and reduce patient distress.
Learn more about Matthew Goodman on Crunchbase…Mapmyhealth design and develop technology enabled care services. Read more aboutMapmyhealth on Crunchbase…
Claire Novorol
Co-Founder & Chief Medical Officer @ Ada Health
FollowClaire Novorol on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”clairenovorol”]
Spoiler title
Claire is a trained doctor, and served as a pediatrician in London before specializing in clinical genetics. With a degree in both pathology and medicine from the University of Bristol and a PhD in Neuroscience from the University of Cambridge, Claire oversees all of Ada’s medical affairs. As an industry thought leader, she gives a voice to the clinicians, patients and doctors to ensure that our product meets their needs.
Learn more about Claire Novorol on Crunchbase… Read more aboutAda Health on Crunchbase…
Charles Niehaus
Chief Medical Officer @ Alliance Medical
FollowCharles Niehaus on Facebook, Twitter or Linkedin.
Spoiler title
Charles is Alliance Medical’s Chief Medical Officer, responsible for the strategic clinical initiatives that will deliver the Group’s evolving service proposition. He was previously Business Development Director for the UK’s largest private healthcare group, General Healthcare. During his medical career, Charles led the South African military’s surgical reaction force.
Learn more about Charles Niehaus on Crunchbase…Alliance Medical is independent provider of imaging services. Read more aboutAlliance Medical on Crunchbase…
Alex Hooi
Chief Medical Officer / Founder @ Callaly
FollowAlex Hooi on Facebook, Twitter or Linkedin.
Spoiler title
Inventor of the Tampliner®, and a co-founder at Callaly.He is also an NHS Gynaecologist, Consultant Specialist and Clinical Director of the Barking Havering and Redbridge University Hospitals NHS Trust and Fellow of the Royal College of Obstetricians and Gynaecologists.
Learn more about Alex Hooi on Crunchbase…Callaly is a period care company that develops and manufactures innovative feminine care products. Read more aboutCallaly on Crunchbase…
Colin Espie
Co-Founder & Chief Medical Officer @ Big Health
FollowColin Espie on Facebook, Twitter or Linkedin.
Read more aboutBig Health on Crunchbase…
Matthew Fenech
Co-founder and Chief Medical Officer @ Una Health
FollowMatthew Fenech on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”mattfenech83″]
Read more aboutUna Health on Crunchbase…
Rowland Illing
Director & Chief Medical Officer, International Government Health @ Amazon Web Services
FollowRowland Illing on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”DrRowIlling”]
Read more aboutAmazon Web Services on Crunchbase…
Kate Hersov
Founder & Chief Medical Officer @ Jumo Health
FollowKate Hersov on Facebook, Twitter or Linkedin.
Read more aboutJumo Health on Crunchbase…
Andrea Spezzi
Chief Medical Officer & Co-Founder @ Orchard Therapeutics
FollowAndrea Spezzi on Facebook, Twitter or Linkedin.
Spoiler title
Andrea is a co-founder of Orchard Therapeutics and brings to the company extensive experience and expertise in the development and execution of all aspects of clinical development and particularly in paediatric rare diseases. Prior to joining Orchard Therapeutics, Andrea served as VP and Medicine Development Leader at GSK Rare Diseases Unit. Previous to joining the GSK Rare Diseases Unit, Andrea was Senior Medical Director at the Immune Inflammation Discovery Performance Unit. Before GSK, Andrea was Global Medical Director R&D at Takeda in the metabolic and cardiovascular area and in charge of the paediatric developments for Takeda Europe R&D. Before that, she worked as Research Physician at Hammersmith Medicines Research. Before moving to the pharmaceutical industry Andrea practiced as a paediatrician for 12 years in Argentina, Spain and UK. Andrea obtained her medical degree from the University of Buenos Aires (UBA) and completed residency in paediatrics and post graduate training in paediatric immunology at the Dr Elizalde Children’s Hospital in Buenos Aires, Argentina. She obtained a Specialist in Pharmaceutical Medicine degree from University of Basel, Switzerland and she is a Fellow of the Faculty of Pharmaceutical Medicine in London, UK (FFPM).
Learn more about Andrea Spezzi on Crunchbase…Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies. Read more aboutOrchard Therapeutics on Crunchbase…
Patrick Keohane
Chief Medical Officer @ Akari Therapeutics
FollowPatrick Keohane on Facebook, Twitter or Linkedin.
Spoiler title
Dr Keohane trained as a Gastroenterologist in the UK NHS, and worked for the Medical Research Council. He has held Project leadership and senior Management positions in Research and Development at Eli Lilly and Astrazeneca, and has been located in US, Japan, and Europe. He joins from Glenmark Pharmaceuticals where he held the position of Chief Medical Officer. Dr Keohane brings extensive experience in the medical assessment and worldwide development and launch of multiple novel oral, biologic, and inhaled medicines, across several Therapeutic areas including Immunology, Diabetes, Respiratory, and Neuroscience.
Learn more about Patrick Keohane on Crunchbase…Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics. Read more aboutAkari Therapeutics on Crunchbase…
Hilary McElwaine-Johnn
Chief Medical Officer @ Psioxus Therapeutics
FollowHilary McElwaine-Johnn on Facebook, Twitter or Linkedin.
Spoiler title
Dr Hilary McElwaine-Johnn is a Physician with over 20 years’ experience in drug development, most recently within venture capital backed biotech companies. Prior to joining PsiOxus in December 2015, Hilary was Chief Medical Officer at Vantia Therapeutics from 2008. Hilary has experience with small molecules and biologics across multiple phases of development in a broad range of therapeutic areas including immunotherapeutics and cancer vaccines. From 2004, Hilary was Vice President Clinical at PowerMed, responsible for clinical development of DNA based vaccines for influenza, chronic viral diseases and cancer, prior to its successful acquisition by Pfizer. Hilary is a graduate of Imperial College London and St Mary’s Hospital Medical School and is a Member of Royal College of Physicians and of the Faculty of Pharmaceutica Medicine.
Learn more about Hilary McElwaine-Johnn on Crunchbase…Psioxus Therapeutics is a cancer gene therapy company delivers medicines of value to patients with cancer. Read more aboutPsioxus Therapeutics on Crunchbase…
Malcolm Finlay
Chief Medical Officer @ Echopoint Medical
FollowMalcolm Finlay on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”mcfinlay”]
Spoiler title
Dr Malcolm Finlay is a Consultant Electrophysiologist and Honorary Senior Lecturer at Barts Heart Centre & UCL, London, specialising in minimally invasive treatments for heart disease. In addition to Echopoint, he has invented several medical technologies, including Epicardio Ltd. (4D heart simulation) and STAR Mapping (Rhythm AI Ltd) to aid treatment of atrial fibrillation. Dr. Finlay qualified from Oxford University in 2001, and gained his PhD in Cardiac Electrophysiology in 2014 from UCL, where he held a Wellcome Trust Research Training Fellowship. His work in technological innovation has been recognised by his appointment to the European Heart Rhythm Association Innovations Committee, he is a faculty member for several national and international academic conferences including Heart Rhythm Congress and the European Heart Rhythm Association. Outside of cardiology, his interests include aviation (holding a private pilot’s license), filmmaking (check out “the last trip” from straight8.net), music and sports.
Learn more about Malcolm Finlay on Crunchbase…Echopoint Medical is a medtech company Read more aboutEchopoint Medical on Crunchbase…
Ezam Mat Ali
Chief Medical Officer @ Hailadoc
FollowEzam Mat Ali on Facebook, Twitter or Linkedin.
Spoiler title
Ezam co-founded Hailadoc in 2015 when he decided to dedicate his career to improving patient care through remote technology. After graduating from Nottingham University, he trained as a paediatrician in London before working as a consultant for seven years at the London North West Healthcare NHS Trust. His enthusiasm in using technology to improve quality of care began when he implemented a high-fidelity simulation programme for clinical teams to carry out emergency treatment. While managing patients with chronic conditions, he became aware that he could potentially deliver better care and improve patient experience if a suitable technology could be developed for remote follow-up care. He decided to complete an MA in Technology in Clinical Practice at University College London. Combining this new knowledge with his clinical experience, Ezam decided to venture into developing a technology that is right for both clinicians and patients. Hailadoc is now working with the NHS, private organisations and individual private practitioners to enable virtual care by making outpatient care more efficient and more convenient for patients. Its technology provides secure video and digital messaging as well as a document sharing capability enabling clinicians to contact, chat and collaborate with patients.
Learn more about Ezam Mat Ali on Crunchbase… Read more aboutHailadoc on Crunchbase…
Arup Paul
Deputy Chief Medical Officer @ AXA PPP Healthcare
FollowArup Paul on Facebook, Twitter or Linkedin.
AXA PPP Healthcare aim is to help people in every aspect of their health. Read more aboutAXA PPP Healthcare on Crunchbase…
Oliver Kessler
Founder, Medical Director and Chief Medical Officer @ Orthox Ltd.
FollowOliver Kessler on Facebook, Twitter or Linkedin.
Spoiler title
Oliver Kessler is a practising knee surgeon based in Zurich with a strong track record of biomaterials research and a focus on meniscal and cartilage repair systems and joint kinematics. He spent 6 years at Stryker Orthopaedics as Director of Orthobiologics supervising a major meniscal tissue engineering programme. He has extensive contacts within both the orthopaedic industry and the surgical community and is responsible for overseeing clinical development of Orthox’s product pipeline.
Learn more about Oliver Kessler on Crunchbase…Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present. Read more aboutOrthox Ltd. on Crunchbase…
Shafi Ahmed
Co-Founder & Chief Medical Officer @ Medical Realities
FollowShafi Ahmed on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”shafiahmed5″]
Spoiler title
Ahmed is a highly experienced general and colorectal surgeon, operating at The Royal London Hospital. In 2007, he was appointed as a Consultant General, Colorectal and Laparoscopic Surgeon at Barts and the London NHS trust. In 2014, he performed the world first live-stream of an operation using Google Glass, which was watched live by 13000 students around the world.
Learn more about Shafi Ahmed on Crunchbase…A new business offering medical training products, specializing in virtual reality and augmented reality. Read more aboutMedical Realities on Crunchbase…
Hannah Allen
Chief Medical Officer @ Daye
FollowHannah Allen on Facebook, Twitter or Linkedin.
Daye creates category-defining products and services that set a new standard for medical research and scientific innovation. Read more aboutDaye on Crunchbase…
Tomohiko Harada
Chief Medical Officer @ Curadim Pharma
FollowTomohiko Harada on Facebook, Twitter or Linkedin.
Read more aboutCuradim Pharma on Crunchbase…
Tomohiko Harada
Chief Medical Officer @ Curadim Pharma
FollowTomohiko Harada on Facebook, Twitter or Linkedin.
Read more aboutCuradim Pharma on Crunchbase…
Gordon Wishart
Founder and Chief Medical Officer @ CHECK4CANCER LTD
FollowGordon Wishart on Facebook, Twitter or Linkedin.
Spoiler title
Gordon Wishart graduated MB ChB from the University of Edinburgh in 1983 followed by an MD in 1992 for a thesis entitled “Aspects of multidrug resistance in breast cancer”. Gordon Wishart received fellowships from the Royal College of Physicians and Surgeons of Glasgow in 1987 and the Royal College of Surgeons of England in 2001. Following his first consultant appointment in Sussex in 1995, Professor GC Wishart moved to Addenbrooke’s Hospital, Cambridge in 1998 to take up the post of consultant breast & endocrine surgeon with a remit to develop and modernise breast cancer services. Professor Gordon C Wishart was Director of the Cambridge Breast Unit from 2005 to 2010 and was appointed as Visiting Professor of Cancer Surgery at Anglia Ruskin University, Cambridge in December 2008. Gordon Wishart has a national and international reputation in the field of breast cancer and has published widely in the field of breast cancer, including sentinel node biopsy, endocrine surgery and breast cancer. A full list of his publications is listed below and can also be found on the PubMed website by searching for Wishart GC. In some of his research articles he will be listed as GC Wishart. Gordon Wishart was instrumental in raising £2 million to build the Cambridge Breast Cancer Research Unit in 2008, a clinical and laboratory facility to support the clinical research programme. He is the lead or co-investigator on clinical trials that have attracted over £2 million in grant funding. He has recently been an advisor to the Department of Health as part of the cancer waiting times and national cancer survivorship initiatives. Gordon Wishart’s main areas of research interest include factors that lead to variation in breast cancer survival and the effect of screen-detection on survival. He recently led a team of clinicians and scientists to produce a new model, Predict, that estimates the survival and treatment benefits following surgery for invasive breast cancer (www.predict.nhs.uk). The second version of Predict, launched in July 2011, is the first clinical prognostication model for breast cancer to include HER2 and the benefit of trastuzumab (Herceptin).
Learn more about Gordon Wishart on Crunchbase… Read more aboutCHECK4CANCER LTD on Crunchbase…
Philip Harris
Chief Medical Officer @ Isotopen Technologien München
FollowPhilip Harris on Facebook, Twitter or Linkedin.
Spoiler title
Philip was appointed Chief Medical Officer of ITM Isotopen Technologien München AG in June 2018. He is responsible for providing clinical leadership to ITM’s radiopharmaceutical development platform. With more than 16 years of leadership experience in industry, Philip has contributed greatly to the development of various theranostic radionuclide therapy platforms in oncology. His previous industry positions include Director of Global Medical Affairs at Pharmacia, Senior Director of Clinical Development at Pfizer, and Vice President at Ipsen. Philip is a distinguished clinical endocrinologist and general physician, with a strong academic background. Prior to moving into industry, he held an academic consultant appointment at King’s College Hospital, London in internal medicine and adult endocrinology. Philip holds a Bachelor of Medicine & Surgery and a PhD from the University of Wales.
Learn more about Philip Harris on Crunchbase… Read more aboutIsotopen Technologien München on Crunchbase…
Andrew Zambanini
Chief Medical Officer @ Atopix Therapeutics
FollowAndrew Zambanini on Facebook, Twitter or Linkedin.
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK Read more aboutAtopix Therapeutics on Crunchbase…
Karol Sikora
Chief Medical Officer @ Rutherford Health
FollowKarol Sikora on Facebook, Twitter or Linkedin.
Spoiler title
Professor Karol Sikora is a founder of the company and has more than forty years of experience as an oncologist treating patients worldwide. He is the Former Chief of the World Health Organisation’s Cancer Programme and is the founding team member and Clinical Director of Cancer Partners UK.
Learn more about Karol Sikora on Crunchbase…Rutherford Health is provides proton beam therapy/radiotherapy services for cancer treatment. Read more aboutRutherford Health on Crunchbase…
Dame Sally Davies
Chief medical officer for England @ Department of Health – GOV.UK
FollowDame Sally Davies on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”cmo_england”]
Department of Health – GOV.UK is a portal to find government services and information. Read more aboutDepartment of Health – GOV.UK on Crunchbase…
Post Views: 395
David Friedland
